Ad is loading...
HCMZX
Price
$21.72
Change
-$0.45 (-2.03%)
Updated
Nov 15 closing price
RWICX
Price
$66.66
Change
-$0.71 (-1.05%)
Updated
Nov 15 closing price
Ad is loading...

HCMZX vs RWICX

Header iconHCMZX vs RWICX Comparison
Open Charts HCMZX vs RWICXBanner chart's image
HCM Dividend Sector Plus R
Price$21.72
Change-$0.45 (-2.03%)
VolumeN/A
CapitalizationN/A
American Funds Capital World Gr&Inc R3
Price$66.66
Change-$0.71 (-1.05%)
VolumeN/A
CapitalizationN/A
HCMZX vs RWICX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HCMZX vs. RWICX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HCMZX is a StrongBuy and RWICX is a Sell.

FUNDAMENTALS
Fundamentals
RWICX has more cash in the bank: 125B vs. HCMZX (1.7B). RWICX pays higher dividends than HCMZX: RWICX (1.43) vs HCMZX (0.34). HCMZX was incepted earlier than RWICX: HCMZX (10 years) vs RWICX (22 years). HCMZX is a more actively managed with annual turnover of: 178.00 vs. RWICX (27.00). HCMZX has a lower initial minimum investment than RWICX: HCMZX (0) vs RWICX (250). HCMZX annual gain was more profitable for investors over the last year : 28.34 vs. RWICX (18.74). HCMZX return over 5 years is better than : 86.31 vs. RWICX (37.64).
HCMZXRWICXHCMZX / RWICX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years22 years-
Gain YTD24.18512.805189%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.7B125B1%
Annual Yield % from dividends0.341.4324%
Returns for 1 year28.3418.74151%
Returns for 3 years1.282.5849%
Returns for 5 years86.3137.64229%
Returns for 10 yearsN/A47.98-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
USNA40.340.90
+2.28%
USANA Health Sciences
CXT55.490.20
+0.36%
Crane NXT Co
SVRE1.29-0.02
-1.80%
SaverOne 2014 Ltd
ILMN135.05-7.19
-5.05%
Illumina
ACRV6.96-0.96
-12.12%
Acrivon Therapeutics